close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar53Point01
Implied share price

Sell Overvalued by 9.1%

5% margin of safety What's this?

EV / EBITDA
Use Average
JNJ
Johnson & Johnson
PFE
Pfizer Inc.
Change
MRK
Merck & Co., Inc.
Change
ABT
Abbott Laboratories
Change
WYE
Wyeth
Change
7.07 7.8 7.24 4.67 8.95 8.53
All amounts in millions
from last financial year
         
Implied Share Price $53.01 $15.84 $55.27 $38.80 $42.13
Market Cap 160,556 131,316 111,072 77,618 67,273
Net Debt -4,884 21,498 7,849 6,523 -2,806
Enterprise Value (EV) 155,672 152,814 118,921 84,142 64,467
Revenue 61,897 50,009 27,428 30,764 22,833
EBITDA 19,964 21,108 25,487 9,397 7,558
Percent 32.3 % 42.2 % 92.9 % 30.5 % 33.1 %
EBIT 17,189 16,351 22,911 7,307 6,550
Percent 27.8 % 32.7 % 83.5 % 23.8 % 28.7 %
Balance Sheet          
Total Assets 94,682 212,949 112,089 52,416 44,031
Total Liabilities 44,094 122,935 53,031 29,560 24,857
Shareholders Equity 50,588 90,014 59,058 22,855 19,173.842

Price history

Comments

No comments yet. Login to comment.